General Announcement::Announcement by TMC Life Sciences Bhd, 3Q2020 results for the period ended 31 May 2020

Issuer & Securities

Issuer/ Manager
THOMSON MEDICAL GROUP LIMITED
Securities
THOMSON MEDICAL GROUP LIMITED - SG1M49904634 - A50
THOMSON MED S$175M4.05%N250128 - SGXF89249654 - RMEB
THOMSON MED S$225M4.8%N220718 - SGXF90488481 - YRYB
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
28-Jul-2020 19:31:40
Status
New
Announcement Sub Title
Announcement by TMC Life Sciences Bhd, 3Q2020 results for the period ended 31 May 2020
Announcement Reference
SG200728OTHRGALQ
Submitted By (Co./ Ind. Name)
Lim Hoi Leong
Designation
Company Secretary
Description (Please provide a detailed description of the event in the box below)
Please see attached.

Unaudited 3Q2020 results for the period ended 31 May 2020
Unaudited 3Q2019 results for the period ended 31 May 2019

Attachments

TMCLS_3Q2020 ended 31 May 2020.pdf
TMCLS_3Q2019 ended 31 May 2019.pdf
Total size =544K